170 related articles for article (PubMed ID: 21936402)
1. Antiproliferative effect of newcastle disease virus strain D90 on human lung cancer cell line A549.
Fu F; Zhao M; Yang YJ; Tong GZ; Yang BF; Song C; Li X
Oncol Res; 2011; 19(7):323-33. PubMed ID: 21936402
[TBL] [Abstract][Full Text] [Related]
2. Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer.
Chai Z; Zhang P; Fu F; Zhang X; Liu Y; Hu L; Li X
Virol J; 2014 May; 11():84. PubMed ID: 24885546
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic induction of lung adenocarcinoma A549 cells infected by recombinant RVG Newcastle disease virus (rL-RVG) in vitro.
Yan Y; Liang B; Zhang J; Liu Y; Bu X
Mol Med Rep; 2015 Jan; 11(1):317-26. PubMed ID: 25322856
[TBL] [Abstract][Full Text] [Related]
4. NDV-D90 inhibits 17β-estradiol-mediated resistance to apoptosis by differentially modulating classic and nonclassic estrogen receptors in breast cancer cells.
Shan P; Tang B; Xie S; Zhang Z; Fan J; Wei Z; Song C
J Cell Biochem; 2021 Jan; 122(1):3-15. PubMed ID: 32985706
[TBL] [Abstract][Full Text] [Related]
5. NDV-D90 suppresses growth of gastric cancer and cancer-related vascularization.
Sui H; Wang K; Xie R; Li X; Li K; Bai Y; Wang X; Bai B; Chen D; Li J; Shen B
Oncotarget; 2017 May; 8(21):34516-34524. PubMed ID: 28388537
[TBL] [Abstract][Full Text] [Related]
6. Antineoplastic activity of Newcastle disease virus strain D90 in oral squamous cell carcinoma.
Zhang CX; Ye LW; Liu Y; Xu XY; Li DR; Yang YQ; Sun LL; Yuan J
Tumour Biol; 2015 Sep; 36(9):7121-31. PubMed ID: 25877754
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells.
Jiang K; Li Y; Zhu Q; Xu J; Wang Y; Deng W; Liu Q; Zhang G; Meng S
BMC Cancer; 2014 Jul; 14():551. PubMed ID: 25078870
[TBL] [Abstract][Full Text] [Related]
8. Newcastle disease virus induces apoptosis in cisplatin-resistant human lung adenocarcinoma A549 cells in vitro and in vivo.
Meng S; Zhou Z; Chen F; Kong X; Liu H; Jiang K; Liu W; Hu M; Zhang X; Ding C; Wu Y
Cancer Lett; 2012 Apr; 317(1):56-64. PubMed ID: 22095029
[TBL] [Abstract][Full Text] [Related]
9. Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model.
Yurchenko KS; Zhou P; Kovner AV; Zavjalov EL; Shestopalova LV; Shestopalov AM
PLoS One; 2018; 13(4):e0195425. PubMed ID: 29621357
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells.
Mansour M; Palese P; Zamarin D
J Virol; 2011 Jun; 85(12):6015-23. PubMed ID: 21471241
[TBL] [Abstract][Full Text] [Related]
11. [Mechanisms of in vitro anti-tumor effects of a Newcastle disease virus].
Meng S; Bai H; Hu M; Liu W; Wang L; Wu Y; Jiao X; Fan J
Wei Sheng Wu Xue Bao; 2009 Apr; 49(4):512-7. PubMed ID: 19621640
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic effects of Hitchner B1 strain of newcastle disease virus against cervical cancer cell proliferation is mediated by the increased expression of cytochrome C, autophagy and apoptotic pathways.
Mozaffari Nejad AS; Fotouhi F; Mehrbod P; Keshavarz M; Alikhani MY; Ghaemi A
Microb Pathog; 2020 Oct; 147():104438. PubMed ID: 32777353
[TBL] [Abstract][Full Text] [Related]
13. Mitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cells.
Meng G; Xia M; Wang D; Chen A; Wang Y; Wang H; Yu D; Wei J
Oncotarget; 2014 Aug; 5(15):6365-74. PubMed ID: 25051374
[TBL] [Abstract][Full Text] [Related]
14. [RL-RVG inhibits proliferation and promotes apoptosis of lung cancer cells in vitro].
Yan Y; Liang B; Zhang J; Jia L; Liu Y; Zhang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):449-52, 457. PubMed ID: 24796735
[TBL] [Abstract][Full Text] [Related]
15. Anti-leukemic activity of Newcastle disease virus strains AF2240 and V4-UPM in murine myelomonocytic leukemia in vivo.
Alabsi AM; Ali R; Ideris A; Omar AR; Bejo MH; Yusoff K; Ali AM
Leuk Res; 2012 May; 36(5):634-45. PubMed ID: 22133641
[TBL] [Abstract][Full Text] [Related]
16. Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells.
Jiang K; Song C; Kong L; Hu L; Lin G; Ye T; Yao G; Wang Y; Chen H; Cheng W; Barr MP; Liu Q; Zhang G; Ding C; Meng S
BMC Cancer; 2018 Jul; 18(1):746. PubMed ID: 30021550
[TBL] [Abstract][Full Text] [Related]
17. Newcastle disease virus strain AF2240 as an oncolytic virus: A review.
Kalyanasundram J; Hamid A; Yusoff K; Chia SL
Acta Trop; 2018 Jul; 183():126-133. PubMed ID: 29626432
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.
Kazimirsky G; Jiang W; Slavin S; Ziv-Av A; Brodie C
Stem Cell Res Ther; 2016 Oct; 7(1):149. PubMed ID: 27724977
[TBL] [Abstract][Full Text] [Related]
19. Caspase Dependent and Independent Anti-hematological Malignancy Activity of AMHA1 Attenuated Newcastle Disease Virus.
Mohammed MS; Al-Taee MF; Al-Shammari AM
Int J Mol Cell Med; 2019; 8(3):211-223. PubMed ID: 32489950
[TBL] [Abstract][Full Text] [Related]
20. Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors.
Yaacov B; Eliahoo E; Lazar I; Ben-Shlomo M; Greenbaum I; Panet A; Zakay-Rones Z
Cancer Gene Ther; 2008 Dec; 15(12):795-807. PubMed ID: 18535620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
